The Riverside Company Invests in Champion Healthcare Technologies and Combines It with HemaTerra
June 6, 2019
The Riverside Company has invested in Champion Healthcare Technologies and combined it with HemaTerra Technologies (a company Riverside invested in earlier) to form a leading medical specialty software business. The combined firm will provide SaaS solutions for implant lifecycle management and blood/plasma collection operations, serving over 500 hospitals and numerous independent blood and plasma centers across the United States.
- Buyers
- The Riverside Company
- Targets
- Champion Healthcare Technologies, HemaTerra Technologies
- Platforms
- HemaTerra Technologies
- Industry
- Cloud & SaaS
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Trinity Hunt Partners Invests in Riverside Services to Launch Commercial Landscaping Platform
March 28, 2023
Environmental Services
Trinity Hunt Partners has launched a national commercial landscaping platform with its investment in Riverside Services, a nearly 50-year-old provider of commercial landscaping, design, maintenance and winter services serving the greater Boston area. Riverside's President Mark Levine will remain a significant shareholder and partner as Trinity Hunt supports growth through organic expansion and add-on acquisitions.
-
InVita Healthcare Technologies / The Riverside Company Acquire BloodHub
October 6, 2022
Cloud & SaaS
InVita Healthcare Technologies, a portfolio company of The Riverside Company, has acquired BloodHub and folded it into InVita's Blood Management Division. Riverside made the investment as an add-on to its InVita platform to expand InVita's blood- and biologics-focused supply chain and laboratory software capabilities across North America.
-
Riverside Adds Transplant Connect to InVita Healthcare Technologies Platform
January 18, 2022
Healthcare Services
The Riverside Company has invested in Transplant Connect, maker of the iTransplant software platform, as an add-on to Riverside’s healthcare software platform InVita Healthcare Technologies. Transplant Connect, founded in 2003 and based in Los Angeles, provides clinical information management, communications, analytics and logistics across the lifecycle of human biologic donation and transplantation.
-
The Riverside Company Acquires HealthTech BioActives (HTBA) from Ferrer
December 13, 2019
Pharmaceuticals
The Riverside Company has acquired HealthTech BioActives S.L. (HTBA), a Spanish manufacturer of APIs, excipients, natural flavors and vitamin B12 derivatives, in a carve-out from Ferrer. Riverside will work with HTBA’s ~140 employees and its manufacturing sites in Beniel (Murcia) and Barcelona to strengthen commercial capabilities, accelerate new product development and expand global sales.
-
Edgewater Capital Partners Acquires Haematologic Technologies
October 11, 2019
Biotechnology
Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.
-
The Riverside Company Invests in HemaTerra Technologies
April 18, 2019
Cloud & SaaS
The Riverside Company has invested in HemaTerra Technologies, a provider of cloud-based SaaS solutions for blood and plasma collection centers, hospitals and related healthcare organizations. Riverside said it will invest in product development, sales and marketing, and strategic partnerships to scale HemaTerra's offerings and support continued growth.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.